MILLER RICHARD A MD - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-02-13
4:31 pm
Purchase
2025-12-3113GCorvus Pharmaceuticals, Inc.
CRVS
MILLER RICHARD A MD6,085,922
7.800%
865,554increase
(+16.58%)
Filing
History
2025-02-13
4:30 pm
Purchase
2024-12-3113GCorvus Pharmaceuticals, Inc.
CRVS
MILLER RICHARD A MD5,220,368
7.700%
5,220,368increase
(New Position)
Filing
History
2024-02-13
6:27 pm
Unchanged
2024-02-1313GCorvus Pharmaceuticals, Inc.
CRVS
MILLER RICHARD A MD0
0.000%
0
(Unchanged)
Filing
2023-02-10
4:00 pm
Unchanged
2023-02-1013GCorvus Pharmaceuticals, Inc.
CRVS
MILLER RICHARD A MD0
0.000%
0
(Unchanged)
Filing
2022-02-11
5:55 pm
Unchanged
2022-02-1113GCorvus Pharmaceuticals, Inc.
CRVS
MILLER RICHARD A MD0
0.000%
0
(Unchanged)
Filing